Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunter von Minckwitz

Showing results (1-10 of 240) with videos related to

Pageof 24
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 19, 2006
Evidence-based treatment of metastatic breast cancer - 2006 recommendations by the AGO Breast CommissionGunter von Minckwitz,
Hematology/Oncology Clinics of North America|August 7, 2013
Neoadjuvant therapy: what are the lessons so far?Gunter von Minckwitz
Breast Cancer (Tokyo, Japan)|January 29, 2008
Breakthrough for neoadjuvant chemotherapyGunter von Minckwitz
Expert Opinion on Pharmacotherapy|February 21, 2007
Docetaxel/anthracycline combinations for breast cancer treatmentGunter von Minckwitz
Breast Cancer Research and Treatment|March 31, 2012
Pathologic complete response after neoadjuvant therapy of breast cancer: pitfalls and shortcomingsGunter von Minckwitz
The Lancet. Oncology|June 21, 2015
A step towards a HER2-positive breast cancer super familyGunter von Minckwitz
Gynakologisch-Geburtshilfliche Rundschau|June 21, 2008
[High-risk situation - which is the best chemotherapy?]Gunter von Minckwitz
Breast Cancer (Tokyo, Japan)|August 15, 2012
Neoadjuvant chemotherapy in breast cancer-insights from the German experienceGunter von Minckwitz
Breast (Edinburgh, Scotland)|October 1, 2013
Selecting the neoadjuvant treatment by molecular subtype: how to maximize the benefit?Gunter von Minckwitz, Caterina Fontanella
Journal of the National Cancer Institute. Monographs|June 12, 2015
Comprehensive Review on the Surrogate Endpoints of Efficacy Proposed or Hypothesized in the Scientific Community TodayGunter von Minckwitz, Caterina Fontanella
Pageof 24

Showing results (1-10 of 240) with videos related to

Sort By:
Pageof 24
European Journal of Cancer (Oxford, England : 1990)|October 19, 2006
Evidence-based treatment of metastatic breast cancer - 2006 recommendations by the AGO Breast CommissionGunter von Minckwitz,
Hematology/Oncology Clinics of North America|August 7, 2013
Neoadjuvant therapy: what are the lessons so far?Gunter von Minckwitz
Breast Cancer (Tokyo, Japan)|January 29, 2008
Breakthrough for neoadjuvant chemotherapyGunter von Minckwitz
Expert Opinion on Pharmacotherapy|February 21, 2007
Docetaxel/anthracycline combinations for breast cancer treatmentGunter von Minckwitz
Breast Cancer Research and Treatment|March 31, 2012
Pathologic complete response after neoadjuvant therapy of breast cancer: pitfalls and shortcomingsGunter von Minckwitz
The Lancet. Oncology|June 21, 2015
A step towards a HER2-positive breast cancer super familyGunter von Minckwitz
Gynakologisch-Geburtshilfliche Rundschau|June 21, 2008
[High-risk situation - which is the best chemotherapy?]Gunter von Minckwitz
Breast Cancer (Tokyo, Japan)|August 15, 2012
Neoadjuvant chemotherapy in breast cancer-insights from the German experienceGunter von Minckwitz
Breast (Edinburgh, Scotland)|October 1, 2013
Selecting the neoadjuvant treatment by molecular subtype: how to maximize the benefit?Gunter von Minckwitz, Caterina Fontanella
Journal of the National Cancer Institute. Monographs|June 12, 2015
Comprehensive Review on the Surrogate Endpoints of Efficacy Proposed or Hypothesized in the Scientific Community TodayGunter von Minckwitz, Caterina Fontanella
Pageof 24